STOCK TITAN

Apollomics CFO acquires 10,000 shares as awards vest

The 6,000 options vest in two stages on March 14 and September 14, 2027, subject to continued service.

(Neutral)
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Apollomics Inc. Chief Financial Officer Peter Kuan-How Lin reported vesting of 10,000 RSUs into 10,000 Class A ordinary shares on September 15, 2026; the derivative transaction row reports 10,000 RSUs following the transaction. On that date, 3,416 shares were delivered or withheld for payment of exercise price or tax liability at a reported $24.02 per share. Lin also received a 6,000-option grant on September 14, 2026, with a $23.18 exercise price and a September 14, 2036 expiration date. Fifty percent vests on March 14, 2027, and the remaining fifty percent on September 14, 2027, subject to continued service. The amendment corrects the option expiration date. No Rule 10b5-1 plan is reported.

Positive

  • None.

Negative

  • None.
Insider LIN PETER KUAN-HOW
Role Chief Financial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units F2, F3 10,000 $0.00 $0.00
Exercise CLASS A ORDINARY SHARES 10,000 $0.00 $0.00
Exercise Price or Tax Liability CLASS A ORDINARY SHARES 3,416 $24.02 $82K
Grant/Award Stock option (Right to Buy) F1 6,000 $0.00 $0.00
Holdings After Transaction: Stock option (Right to Buy) — 6,000 contracts (Direct); Restricted Stock Units — 10,000 contracts (Direct); CLASS A ORDINARY SHARES — 55,563 shares (Direct)
Footnotes (3)
  1. F1. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
  2. F2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
  3. F3. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 10,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 10,000 RSUs on September 15, 2026.
RSUs vested 10,000 RSUs September 15, 2026
Class A ordinary shares acquired 10,000 shares Upon RSU vesting on September 15, 2026
RSUs following transaction 10,000 RSUs Derivative transaction row; September 15, 2026
Shares delivered or withheld 3,416 shares Payment of exercise price or tax liability; September 15, 2026
Reported per-share price $24.02 per share Shares delivered or withheld on September 15, 2026
Stock options granted 6,000 options Granted September 14, 2026
Option exercise price $23.18 per share Stock option granted September 14, 2026
Option expiration date September 14, 2036 Expiration date corrected by the amendment
restricted stock unit financial
"Each restricted stock unit represents a contingent right"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vests and becomes exercisable financial
"The option vests and becomes exercisable over a one-year period"
Rule 10b5-1 regulatory
"No Rule 10b5-1 plan is reported"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many APLM shares did the CFO acquire when the RSUs vested?

Peter Kuan-How Lin acquired 10,000 Class A ordinary shares when 10,000 RSUs vested on September 15, 2026. On that date, 3,416 shares were delivered or withheld for payment of exercise price or tax liability, at a reported price of $24.02 per share.

What are the terms of the APLM CFO's stock option grant?

Lin received 6,000 options on September 14, 2026, with a $23.18 exercise price and a September 14, 2036 expiration date. Fifty percent vests on March 14, 2027, and the remaining fifty percent on September 14, 2027, subject to continued service.

Were the APLM CFO's transactions under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for the transactions.

What expiration date does APLM's amended option report list?

The option expiration date is September 14, 2036; the amendment corrects the expiration date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LIN PETER KUAN-HOW

(Last)(First)(Middle)
668 ARROW GRAND CIR. SUITE 206

(Street)
COVINA CALIFORNIA 91772

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
09/17/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
CLASS A ORDINARY SHARES09/15/2026M10,000A$058,979D
CLASS A ORDINARY SHARES09/15/2026F3,416D$24.0255,563D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (Right to Buy)$23.1809/14/2026A6,000 (1)09/14/2036CLASS A ORDINARY SHARES6,000$06,000D
Restricted Stock Units(2)09/15/2026M10,000 (3) (3)CLASS A ORDINARY SHARES10,000$010,000D
Explanation of Responses:
1. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
3. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 10,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 10,000 RSUs on September 15, 2026.
Remarks:
This Form 4 is being amended to correct the expiration date of the stock option.
/s/ Alison M. Pear, Attorney-In-Fact09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading